BD Illuminates the Role of Microbiology in Sepsis Core Measures
Yorba Linda, Ca (PRWEB) September 11, 2017 -- As part of BD’s commitment to increased awareness to the health and financial burden associated with Sepsis, BD is sponsoring an educational webinar in recognition of World Sepsis Day. This global disease, impacting an estimated 31 Million people worldwide, with an estimated five million deaths annually, is preventable and treatable through increased awareness and education.
This session will frame the importance of blood cultures as they relate to the Surviving Sepsis Campaign and to healthcare’s efforts to reduce mortality from sepsis. It will also provide tips for laboratorians who seek to better characterize and report their quality metrics and associated improvement in their metrics to provide evidence of the laboratory contribution to sepsis programs.
Through this webinar, participants will be introduced to the concepts of core measures for sepsis and their impact on hospitals. The speaker will give examples of blood culture metrics and how they can support their organization’s sepsis program, as well as review statistics that support laboratory quality initiatives for blood culture processes.
The team at BD has arranged for Dr. Donna Wolk, a system director for Clinical and Molecular Microbiology at Geisinger Health System, to be the speaker for this event.
After receiving her undergraduate degree from Penn State University, Wolk went on to earn her Master of Health Administration from Wilkes University and a doctorate in medical microbiology from the University of Arizona. As a Diplomate of the American Board of Medical Microbiology (ABMM), Dr. Wolk's professional practice extends to the national and international level, supporting initiatives in clinical and molecular microbiology and laboratory leadership. She currently serves as system director for Clinical and Molecular Microbiology at Geisinger Health System, an integrated delivery system in Pennsylvania.
LabRoots will host the webinar September 13, 2017, beginning at 10:00 a.m. PDT, 1:00 p.m. EDT. To learn more about this event, discover the continuing education credits offered, or to register for free, click here.
About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news and science-themed apparel, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.
Karen Sorenson, LabRoots, Inc., http://www.LabRoots.com, +1 (619) 861-0590, [email protected]
Share this article